Hans, C. P. et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
In the present study, we have expanded these results using a tissue microarray.
Using a tissue microarray (TMA) of eRMS patients, we found that high expression of CD133 correlates with poor overall survival.
We extended these analyses of MM by immunohistochemical studies using a tissue microarray containing bone marrow biopsies from 20 normal controls and 20 patients with MM.
MGMT-immunoreactivity was assessed of 285 brain metastases using a tissue microarray (77 lung carcinomas, 62 breast carcinomas, 42 renal cell carcinomas, 104 malignant melanomas).
We examined the expression of a subset of genes of interest in BPH tissues at the protein level by immunohistochemistry (IHC), using a tissue microarray containing sections with BPH pathologies ranging from minimal to severe.
Single 0.6 mm tissue cores targeted to areas with tumor that had been identified and marked by a pathologist (MES) were obtained from each tumor block for DNA extraction, using a tissue microarray coring needle for each sample.
To characterize the clinical relevance of two highly-ranked differentially-expressed genes, we analyzed the expression of secreted phosphoprotein 1 (SPP1 or osteopontin) and lymphoid enhancer factor-1 (LEF1) by immunohistochemistry using a tissue microarray (TMA) representing an independent set of 154 patients with primary CRC.
Immunohistochemical staining for ER and PgR status was performed using a tissue microarray [ 11- 14].
Furthermore, we have confirmed the alteration in the expression of galectin-7 using a tissue microarray.
Using a tissue microarray assay, we found that Btk is overexpressed in prostate cancer tissues.
